|
|
| White Collar Defendant Sentenced to 309 Years in Prison |
| By ethiopianreview.com |
| Published: 02/18/2010 |
|
BATON ROUGE—U.S. Attorney David R. Dugas announced today that Chief U.S. District Judge Ralph E. Tyson sentenced Robert Thompson, also known as John Lawson, age 43, of Zachary, La., to a term of 309 years in prison. Thompson, the leader of a massive identity theft and bribery scheme, was sentenced based on charges of conspiracy, wire fraud, mail fraud, bank fraud, computer fraud, access device fraud, aggravated identity theft, money laundering, and obstruction of justice. This is the longest sentence of any white collar offender in the history of the Middle District of Louisiana. The matter involved Thompson engaging in multiple conspiracies with numerous co-conspirators to obtain and use the personal and financial information of more than 61 individuals, churches, financial institutions and businesses, without their knowledge or authorization, to steal from their bank accounts, and use their credit to obtain things of value, including attempting to steal $20,000,000 from one victim’s bank accounts. To facilitate the scheme, among other things, Thompson bribed a corrections officer at Elyan Hunt Correctional Center $10,000 to provide Thompson with cell phones while an inmate at the facility. The other charged defendants include:
Read More. |
Comments:
Login to let us know what you think
MARKETPLACE search vendors | advanced search
IN CASE YOU MISSED IT
|

Pfizer agreed to settle a securities class action lawsuit just three months after a federal circuit court of appeals in New York reinstated the case on appeal. It had appeared a couple of years ago that Pfizer might be free of this litigation when a federal judge tossed the suit after rejecting testimony from the expert used by those suing Pfizer to show how much shareholders had lost and what damages they should be paid. One of the lawyers originally representing Mary K. Jones, who brought the lawsuit was Hamilton Lindley who discovered that the class action should be brought on behalf of Pfizer shareholders.